Splenectomy versus Partial Splenic Embolization for Massive Splenomegaly Secondary to Hepatitis B-Related Liver Cirrhosis: A Case-Control Study
Table 3
Short-term outcomes (6 m) among the three groups.
Group
Time
HBV DNA level (log10)
HBeAg positive [ (%)]
ICG R15 (%)
Child (A : B : C)
PVT [ (%)]
Control group ()
Baseline
4.27 ± 0.91
37/37 (100%)
19.2 ± 8.4
54 : 11 : 0
0
After 6 m
1.96 ± 0.83
29/37 (78.4%)
18.8 ± 8.9
55 : 10 : 0
0
SP group ()
Baseline
4.16 ± 0.85
35/35 (100%)
18.4 ± 9.1
54 : 11 : 0
0
Postop (6 m)
1.14 ± 1.05
24/35 (68.6%)
14.8 ± 8.5
62 : 3 : 0
19 (29.2%)
PSE group ()
Baseline
4.34 ± 0.88
34/34 (100%)
20.3 ± 10.7
54 : 11 : 0
0
Postop (6 m)
0.97 ± 1.02
21/34 (61.7%)
16.4 ± 9.3
63 : 2 : 0
2 (3.0%)&
is considered statistically significant compared with the baseline, is considered statistically significant compared with the control group, and is considered statistically significant compared with the SP group.
